Naprosyn (Naproxen)

Naproxen, the active ingredient in Naprosyn, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a topical formulation for external use. It treats pain and inflammation, particularly musculoskeletal discomfort, in adult patients.

GNH USA supplies Naprosyn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen, the NSAID in Naprosyn, works on inflammatory pathways to relieve pain in various musculoskeletal conditions.

- Musculoskeletal pain: reduces localized pain and swelling at the site of application. - Osteoarthritis: alleviates joint discomfort and stiffness during movement. - Rheumatoid arthritis flare‑ups: helps control inflammation and pain in affected joints.

Adverse reactions may occur with topical naproxen use.

Common Side Effects: - Skin irritation at the application site. - Redness or erythema. - Itching or mild rash. - Dryness of the skin. - Burning sensation.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis). - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiovascular events such as myocardial infarction. - Gastrointestinal ulceration or bleeding. - Liver enzyme elevation.

When using Naprosyn topical, consider the following safety measures.

- Contraindications: avoid use in patients with known hypersensitivity to naproxen or other NSAIDs. - Pregnancy: consult a healthcare professional before use; safety data are limited. - Breastfeeding: discuss potential risks with a clinician. - Drug interactions: review concomitant medications for possible NSAID interactions. - Application area: limit to intact skin and avoid covering with occlusive dressings unless directed. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Naproxen can interact with several drug classes; monitoring is advised.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may enhance renal adverse effects. - Lithium: naproxen can raise lithium serum levels. - Methotrexate: potential for increased toxicity. - Corticosteroids: increased risk of gastrointestinal ulceration.